(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -94.48%-254.42K | 44.07%-490.82K | 54.34%-93.12K | 66.54%-62.36K | 55.07%-204.52K | -307.84%-130.82K | 20.95%-877.56K | -123.47%-203.94K | 27.68%-186.37K | -84.22%-455.17K |
Net income from continuing operations | -464.76%-529.31K | 33.17%-520.37K | 22.41%-157.92K | 70.54%-59.84K | 38.61%-208.89K | -194.83%-93.72K | 27.54%-778.66K | -5.16%-203.52K | 9.07%-203.1K | 5.50%-340.24K |
Remuneration paid in stock | --266.19K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non cashItems | --95K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | -132.63%-86.3K | 129.88%29.55K | 15,827.91%64.8K | -115.07%-2.52K | 103.80%4.37K | -12,737.37%-37.1K | -6.60%-98.9K | -100.40%-412 | 148.71%16.73K | -306.47%-114.93K |
-Change in receivables | -39.63%-22.32K | -162.95%-12.32K | -322.96%-11.38K | -70.44%10.24K | 110.83%4.81K | ---15.99K | -109.22%-4.69K | -83.56%5.11K | 409.88%34.64K | -837.39%-44.43K |
-Change in prepaid assets | -106.87%-40.26K | -3,574.70%-2.88K | -80.26%1.43K | 50.88%-10.52K | 259.60%25.67K | -372.62%-19.46K | -99.82%83 | 1.15%7.22K | 13.11%-21.42K | 29.94%7.14K |
-Change in payables and accrued expense | -1,336.71%-23.72K | 147.46%44.75K | 686.92%74.76K | -163.90%-2.24K | 66.37%-26.11K | 77.77%-1.65K | 50.17%-94.3K | -119.88%-12.74K | 137.76%3.51K | -275.88%-77.64K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -94.48%-254.42K | 44.07%-490.82K | 54.34%-93.12K | 66.54%-62.36K | 55.07%-204.52K | -307.84%-130.82K | 20.95%-877.56K | -123.47%-203.94K | 27.68%-186.37K | -84.22%-455.17K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -383.96%-98.24K | -88.06K | -20.3K | 0 | ||||||
Net PPE purchase and sale | ---- | -383.96%-98.24K | ---88.06K | ---- | ---- | ---- | ---20.3K | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | -383.96%-98.24K | ---88.06K | ---- | ---- | ---- | ---20.3K | --0 | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1.44M | 0 | ||||||||
Net common stock issuance | ---- | --1.44M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | --1.44M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | 163.07%1.37M | -63.26%520.61K | -83.41%107.52K | -69.92%234.05K | -69.42%391.8K | -63.26%520.61K | -43.93%1.42M | -58.34%648.04K | -56.67%778.22K | -37.29%1.28M |
Current changes in cash | -94.48%-254.42K | 194.57%849.07K | 716.35%1.26M | 64.90%-72.54K | 55.07%-204.52K | -307.84%-130.82K | 19.12%-897.86K | -123.47%-203.94K | 19.80%-206.67K | -84.22%-455.17K |
Effect of exchange rate changes | -63.45%734 | -108.07%-125 | -93.35%5.09K | -170.60%-54K | 197.82%46.78K | 101.94%2.01K | --1.55K | 261.64%76.51K | 340.16%76.49K | ---47.82K |
End cash Position | 184.81%1.12M | 163.07%1.37M | 163.07%1.37M | -83.41%107.52K | -69.92%234.05K | -69.42%391.8K | -63.26%520.61K | -63.26%520.61K | -58.34%648.04K | -56.67%778.22K |
Free cash from | -94.48%-254.42K | 34.39%-589.06K | 11.16%-181.18K | 64.90%-72.54K | 55.07%-204.52K | -307.84%-130.82K | 19.12%-897.86K | -123.47%-203.94K | 19.80%-206.67K | -84.22%-455.17K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data